Solta Medical, Inc. (SLTM) Reports In-Line Q2 EPS, Lowers FY11 Sales Guidance
Tweet
Share
E-mailGet Alerts SLTM Hot Sheet
Join SI Premium – FREE
Solta Medical, Inc. (NASDAQ: SLTM) reported Q2 EPS of $0.02, in-line with the analyst estimate of $0.02. Revenue for the quarter came in at $29 million versus the consensus estimate of $31.79 million.
Solta Medical, Inc. sees FY2011 non-GAAP gross margin in the range of 66% to 68%. Solta Medical, Inc. sees FY2011 revenue of $115-$120 million, versus prior guidance of $118-$123 million and the consensus of $120.21 million.
Solta Medical, Inc. sees FY2011 non-GAAP gross margin in the range of 66% to 68%. Solta Medical, Inc. sees FY2011 revenue of $115-$120 million, versus prior guidance of $118-$123 million and the consensus of $120.21 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- KULR Technology Group (KULR) Misses Q2 EPS by 39c
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
